Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Dentsply Sirona Inc. common stock during the specified Class Period, highlighting potential investor compensation opportunities [1][2]. Group 1: Lawsuit Details - The class action lawsuit pertains to Dentsply Sirona Inc. common stock purchases made between December 1, 2022, and November 6, 2024 [1]. - Investors who purchased Dentsply common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by January 27, 2025, to represent other class members in the litigation [1][3]. Group 2: Allegations Against Dentsply - The lawsuit alleges that Dentsply made false and misleading statements regarding its Byte aligner solution, targeting low-income individuals without proper dental care [5]. - It is claimed that the sales strategy led to sales employees selling to patients who were contraindicated for treatment, resulting in inadequate patient onboarding processes [5]. - Reports of patient injuries related to Byte aligners were allegedly ignored by Dentsply, which failed to notify the FDA as required [5]. - The lawsuit asserts that Dentsply materially overstated the goodwill value of Byte and that positive statements about the company's business were misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].
ROSEN, A LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY